Thomas C Reynolds's Net Worth

$8.85 Million

Estimate Recalculated Dec 3, 2025 08:04PM EST

Who is Thomas C Reynolds

Thomas C Reynolds has an estimated net worth of $8.85 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, MEI Pharma, Inc., and Trillium Therapeutics Inc..

SEC CIK

Thomas C Reynolds's CIK is 0001393945

Past Insider Trading and Trends

2012 was Thomas C Reynolds's most active year for acquiring shares with 31 total transactions. Thomas C Reynolds's most active month to acquire stocks was the month of July. 2012 was Thomas C Reynolds's most active year for disposing of shares, totalling 56 transactions. Thomas C Reynolds's most active month to dispose stocks was the month of October. 2007 saw Thomas C Reynolds paying a total of $3,205,562.50 for 381,250 shares, this is the most they've acquired in one year. In 2012 Thomas C Reynolds cashed out on 812,154 shares for a total of $9,638,800.69, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SEATTLE GENETICS INC /WA

Chief Medical Officer
Updated Jan 29, 2013
Form 4
-4.00%
-7.29K
$21.57
-$124.24K
Jan 29, 2013
175.10K
Sale
ScheduledJan 25 - Jan 28
Form 4
-41.80%
-125.08K
$19.81
-$2.05M
Jan 17, 2013
174.16K
Sale
ScheduledJan 15
Form 4
-38.24%
-66.59K
$18.49
-$970.15K
Dec 10, 2012
107.53K
Sale
Dec 06 - Dec 10
Form 4
-17.38%
-40.00K
$18.86
-$538.70K
Dec 06, 2012
190.21K
Sale
Dec 04 - Dec 05
Form 4
-14.80%
-40.00K
$18.73
-$534.90K
Dec 03, 2012
230.21K
Sale
Nov 29 - Dec 03
Form 4
-12.11%
-30.00K
$19.25
-$365.50K
Nov 26, 2012
217.80K
Sale
Nov 21 - Nov 26
Form 4
-7.47%
-20.00K
$20.13
-$192.69K
Nov 20, 2012
247.80K
Sale
Nov 19 - Nov 20
Form 4
-45.73%
-48.54K
$19.00
-$1.04M
Sep 10, 2012
57.60K
Sale
ScheduledSep 06
Form 4
287.97%
91.00K
$26.10
$1.70M
Aug 22, 2012
122.60K
Grant
Aug 20
Form 4
-2.96%
-949.00
$14.00
-$10.92K
May 17, 2012
31.07K
Sale
ScheduledMay 15
Form 4
-55.54%
-40.00K
$14.00
-$460.40K
Apr 26, 2012
32.02K
Sale
ScheduledApr 25
Form 4
-35.71%
-40.00K
$14.01
-$461.50K
Mar 23, 2012
72.02K
Sale
ScheduledMar 22
Form 4
-26.31%
-40.00K
$14.00
-$460.40K
Mar 20, 2012
112.02K
Sale
ScheduledMar 16 - Mar 19
Form 4
-20.93%
-40.00K
$14.00
-$460.40K
Jan 30, 2012
151.12K
Sale
ScheduledJan 27
Form 4
5,601.66%
127.89K
$15.46
$1.55M
Aug 24, 2011
130.17K
Grant
Aug 19 - Aug 24
Form 4
-50.84%
-1.54K
$17.37
-$26.73K
Aug 03, 2011
1.49K
Sale
ScheduledAug 01
Form 4
-21.27%
-20.00K
$14.90
-$152.33K
May 20, 2011
74.01K
Sale
ScheduledMay 18 - May 19
Form 4
-10.87%
-20.00K
$13.02
-$191.20K
May 13, 2011
163.98K
Sale
ScheduledMay 13
Form 4
-6.08%
-11.91K
$12.60
-$119.57K
May 03, 2011
183.98K
Sale
ScheduledApr 29
Form 4
-11.28%
-25.00K
$12.60
-$217.75K
Oct 12, 2010
196.67K
Sale
ScheduledOct 11
Form 4
-10.14%
-25.00K
$11.60
-$167.75K
Sep 29, 2010
221.67K
Sale
ScheduledSep 27
Form 4
125.00K
$12.00
$1.50M
Sep 07, 2010
125.00K
Grant
Aug 27
Form 4
-9.24%
-25.00K
$9.42
-$323.75K
May 05, 2010
245.46K
Sale
ScheduledMay 03
Form 4
125.00K
$12.16
$1.52M
Aug 26, 2009
125.00K
Grant
Aug 25
Form 4
-8.54%
-25.00K
$11.42
-$417.45K
Jul 31, 2009
267.86K
Sale
Jul 30
Form 4
-4.05%
-12.31K
$9.31
-$154.11K
Sep 24, 2008
291.78K
Sale
Sep 22
Form 4
100.00K
$11.09
$1.11M
Aug 29, 2008
100.00K
Grant
Aug 27
Form 4
31.25K
$10.29
$321.56K
Aug 30, 2007
31.25K
Grant
Aug 28
Form 4
350.00K
$8.24
$2.88M
Apr 04, 2007
350.00K
Grant
Apr 02
Form 3
Mar 21, 2007
Showing 30 results

MEI Pharma, Inc.

Investor
Updated Oct 12, 2023
Form 4
10.00K
Oct 12, 2023
10.00K
Grant
Sep 29
Form 4
87.50K
Jul 07, 2022
367.50K
Grant
Jul 05
Form 4
50.00K
Jul 06, 2021
280.00K
Grant
Jul 01
Form 4
50.00K
Jul 07, 2020
230.00K
Grant
Jul 02
Form 4
10.00K
$1.60
$16.00K
Dec 20, 2019
10.00K
Purchase
Dec 19
Form 4
40.00K
Jul 03, 2019
40.00K
Grant
Jul 01
Form 4
40.00K
Jul 16, 2018
40.00K
Grant
Jul 12
Form 4
49.35%
40.00K
Jul 10, 2017
121.05K
Grant
Jul 06
Form 4
97.44%
40.00K
Aug 01, 2016
81.05K
Grant
Jul 29
Form 4
95.02%
20.00K
Jul 29, 2015
41.05K
Grant
Jul 28
Form 4
61.31%
8.00K
Jul 16, 2014
21.05K
Grant
Jul 14
Form 4
106.50%
6.73K
Jul 17, 2013
13.05K
Grant
Jul 15
Form 4
6.32K
Feb 11, 2013
6.32K
Grant
Feb 07
Form 3
Feb 11, 2013
Showing 14 results

Trillium Therapeutics Inc.

Investor
Updated Jan 04, 2021
Form 3
Jan 04, 2021
Showing 1 results